Mycobacterium tuberculosis infection in patients with inflammatory bowel disease who received Anti-Tumor Necrosis Factor treatment in Russia

X. Frolova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation)

Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Session: Tuberculosis and comorbidities
Session type: E-poster session
Number: 482
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
X. Frolova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation). Mycobacterium tuberculosis infection in patients with inflammatory bowel disease who received Anti-Tumor Necrosis Factor treatment in Russia. 482

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Necrosis as a predictor of infection in granulomatous lung disease
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013

Treatment of refractory mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013

Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test?
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Efficacy and safety of kanamycin addition in patients with drug-refractory mycobacterium avium complex lung disease
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Retrospective observation of mycobacterium avium complex lung disease followed without treatment
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011


Incidence and outcomes of Mycobacterium abscesssus infections in non-Cystic Fibrosis patients
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016

Nontuberculous mycobacterial lung disease caused by Mycobacterium parascrofulaceum in an immunocompetent patient
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Analysis of clinical course after pulmonary resection for mycobacterium avium complex lung disease in our hospital
Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions
Year: 2014